Group One Trading’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Group One Trading’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,800	Closed	-$15.3K	–	8501
2023 Q3	$15.3K	Buy	+3,800	New	+$28.2K	﹤0.01%	6087
2023 Q1	–	Sell	-550	Closed	-$3.99K	–	8205
2022 Q4	$3.99K	Buy	550 +470	+588%	+$3.96K	﹤0.01%	6428
2022 Q3	$1K	Sell	80 -50	-38%	-$933	﹤0.01%	7417
2022 Q2	$2K	Sell	130 -20	-13%	-$518	﹤0.01%	7476
2022 Q1	$7K	Buy	150 +70	+88%	+$3.63K	﹤0.01%	7341
2021 Q4	$6K	Buy	80 +20	+33%	+$1.36K	﹤0.01%	7606
2021 Q3	$5K	Sell	60 -620	-91%	-$62.3K	﹤0.01%	7776
2021 Q2	$94K	Buy	+680	New	+$130K	﹤0.01%	6033

Group One Trading's HARP Position: Q1 2024 in Review

Group One Trading sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 35 shares — an estimated $398 sold.

Group One Trading first reported a position in HARP in Q1 2021 and held it in 10 quarters. The position peaked at $28K in Q1 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Group One Trading reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Group One Trading sold 35 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $398.
Group One Trading first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Group One Trading's Harpoon Therapeutics, Inc. Common Stock position peaked at $28K in Q1 2021.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.